Juniper Pharmaceuticals names CFO replacement | S&P Global Market Intelligence

Workflow Solutions
Products
See more S&P Global Solutions
See More IHS Markit Solutions
Content
How We Can Help
See More
News & Insights Topics
See More
Featured Events
In PersonPolitics & Policy: Market Impacts and Mid-Year Outlooks
- 06/24/2022
- Sofitel Washington DC Lafayette Square
- 8:30 AM – 12:00 PM ET
Webinar ReplaysExpand Your Perspective: Analyzing Deal Activity & Drivers Across the Capital Markets
- 06/08/2022
- On-Demand
- 1 Hour
In Person451Nexus
- 10/03/2022
- ARIA Resort and Casino, Las Vegas, Nevada
- ARIA Resort and Casino
Platforms
Other Products
- Leveraged Commentary and Data
- Research Online

Juniper Pharmaceuticals names CFO replacement

Commercial Banking: June 22nd Edition

Understanding Loss Given Default A Review of Three Approaches

Insight Weekly: Path to net-zero; US manufacturing momentum; China's lithium M&A frenzy

Commercial Banking Newsletter June Edition - 2022

20 Dec, 2016 | 10:05

Juniper Pharmaceuticals names CFO replacement

Author Muhammad Ahmer Gul Khan
Theme Healthcare & Pharmaceuticals

Jeffrey Young is replacing George Elston as Juniper Pharmaceuticals Inc.'s treasurer, secretary and CFO, starting Jan. 1, 2017.

Young joins the company from OvaScience, where he served as treasurer and CFO.